Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan

Study type: Observational

Funder types: Industry

Identifiers

NCT02238262

502.374

Details and patient eligibility

About

The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals

Enrollment: 2,318 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diagnosis of essential hypertension
• Minimum age of 18 years

Exclusion criteria

• NA

Trial design

2,318 participants in 1 patient group

essential hypertension patients

Treatment:

Drug: Telmisartan